In another study, Wang et al. developed a PEG-b-poly (L-alanine) hydrogel, in which the tumor cell lysate, GM-CSF, and a dual immune checkpoint inhibitor (anti-CTLA-4/PD-1 antibodies) were easily loaded into (Song et al., 2019). The gene discussed is CSF2; the disease is neoplasm.